Search

Author/Creator Loberg, Lise I.

2. Efficacy and safety results of depatuxizumab mafodotin (ABT‐414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor. Issue 10 (13th March 2018)

Authors:
Goss, Glenwood D.; Vokes, Everett E.; Gordon, Michael S.; Gandhi, Leena; Papadopoulos, Kyriakos P.; Rasco, Drew W.; Fischer, JuDee S.; Chu, Katharine L.; Ames, William W.; Mittapalli, Rajendar K.; Lee, Ho‐Jin; Zeng, Jiewei; Roberts‐Rapp, Lisa A.; Loberg, Lise I.; Ansell, Peter J.; Reilly, Edward ...
Journal:
Cancer
Issue:
Volume 124:Issue 10(2018)
Page Start:
2174
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Off-target binding of an anti-amyloid beta monoclonal antibody to platelet factor 4 causes acute and chronic toxicity in cynomolgus monkeys. Issue 1 (1st January 2021)

Authors:
Loberg, Lise I.; Chhaya, Meha; Ibraghimov, Alexander; Tarcsa, Edit; Striebinger, Andreas; Popp, Andreas; Huang, Lili; Oellien, Frank; Barghorn, Stefan
Journal:
MAbs
Issue:
Volume 13:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Strategies and Recommendations for Using a Data‐Driven and Risk‐Based Approach in the Selection of First‐in‐Human Starting Dose: An International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) Assessment. Issue 6 (3rd November 2020)

Authors:
Leach, Michael W.; Clarke, David O.; Dudal, Sherri; Han, Chao; Li, Chunze; Yang, Zheng; Brennan, Frank R.; Bailey, Wendy J.; Chen, Yingxue; Deslandes, Antoine; Loberg, Lise I.; Mayawala, Kapil; Rogge, Mark C.; Todd, Marque; Chemuturi, Nagendra V.
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 109:Issue 6(2021)
Page Start:
1395
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗